$3.37 -0.03 (-0.88%)
12/3/2009 4:01 PM

K V Pharmaceutical Company (KV-A)

CAPS Rating: 5 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Recs

0
Member Avatar Gir013 (99.21) Submitted: 6/26/2009 5:34:01 AM : Outperform Start Price: $2.81 KV-A Score: -0.93

Value screener pick, starting to pick up steam after the FDA ruling, up over 60% since I bought it

Report this Post 0 Comments

Featured Broker Partners